May 10 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2017 Mar 31, 2016 Mar 31, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 4.70 5.35 4.60 2.20
(-12.0 pct) (-2.4 pct) (-2.2 pct) (-6.6 pct)
Operating 474 mln 442 mln 350 mln 150 mln
(+7.3 pct) (+10.2 pct) (-26.3 pct) (-38.9 pct)
Recurring 468 mln 440 mln 340 mln 145 mln
(+6.2 pct) (+12.3 pct) (-27.4 pct) (-35.5 pct)
Net 309 mln 296 mln 235 mln 100 mln
(+4.5 pct) (+28.7 pct) (-24.1 pct) (-31.8 pct)
EPS 74.12 yen 69.39 yen 56.22 yen 23.92 yen
Ann Div 12.50 yen 12.50 yen 12.50 yen
-Q2 Div NIL NIL NIL
-Q4 Div 12.50 yen 12.50 yen 12.50 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T
((Tokyo Headline News Desk +813 6441 1812))